10-K · March 10, 2026
Nature’s Sunshine reported multi-quarter momentum that produced higher full-year results: consolidated revenue rose to $480.0 million in 2025 vs $455.0 million in 2024 (sum of quarterly results), with gross margin…
Earnings analysis · 10-Q
NATR earnings analysis
Filed May 7, 2026 · Our reading of the company's report
The latest report
Nature's Sunshine Products, Inc. reported solid financial performance in Q1 2026, with net sales increasing 8.5% year-over-year to $122.9 million and diluted EPS rising to $0.3, exceeding expectations. In addition, both…
Read full summary
Nature's Sunshine Products, Inc. reported solid financial performance in Q1 2026, with net sales increasing 8.5% year-over-year to $122.9 million and diluted EPS rising to $0.3, exceeding expectations. In addition, both gross and operating margins improved, reflecting effective cost management and operational efficiencies, although cash flows from operations turned negative this quarter due to timing issues.
Gross and operating margin
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
From revenue to operating profit
Where each $100 of revenue went in this report.
Cost of sales, operating expenses, and what remained. Figures are rounded to whole dollars.
Where revenue came from
The business segments reported by the company.
Shares of the segments disclosed in this filing, largest first.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Reported figures
- Earnings per share
- $0.3
What stood out
-
Revenue Growth of 8.5% YOY
Net sales for Q1 2026 reached $122.9 million, up from $113.2 million in Q1 2025.
-
EPS Beats Estimates
Diluted EPS for Q1 2026 was $0.3, surpassing the estimate of $0.2.
-
Improved Gross Margin
Gross margin increased to 73.2%, up from 72.1% in the same quarter last year.
-
Strong Segment Performance
Latin America and Europe saw net sales increase of approximately 9.7% and 9.5% YOY, respectively.
-
Operating Income Increase
Operating income rose to $9.5 million for the quarter, a 54.7% increase from $6.2 million in Q1 2025.
-
Maintained Strong Cash Position
End of period cash and cash equivalents stood at $87.6 million, up from $85.9 million as of December 31, 2025.
What to watch
-
Decline in Asia Market
Net sales in Taiwan decreased by $2.9 million or 16.1%, suggesting challenges in that market.
-
Increased SG&A Expenses
Selling, general and administrative expenses increased by $3.0 million to $43.5 million compared to Q1 2025.
-
Foreign Exchange Exposure
Ongoing geopolitical tensions continue to pose risks related to foreign currency fluctuations affecting operations.
Management's outlook
Qualitative outlook discusses continued growth but lacks specific numeric guidance.
Earlier filings 4
10-Q · November 6, 2025
Nature's Sunshine reported Q3 net sales of $128,339,000 (up $13,724,000 or ~12.0% vs Q3 2024) with gross profit of $94,049,000 (gross margin ~73.3%) and diluted EPS of $0.30. Operating income rose to $8,975,000…
10-Q · July 31, 2025
Nature’s Sunshine reported Q2 net sales of $114,750,000 (up from $110,551,000 in Q2 2024) and diluted EPS of $0.28 (vs $0.07 prior year), aided by a $3,026,000 foreign exchange gain. Gross profit was $82,299,000 (gross…
10-K · March 11, 2025
Nature’s Sunshine positions itself as a natural health and wellness manufacturer and direct-selling company with a product line of over 800 SKUs sold through a global network of independent consultants across four…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.